-
February 02, 2012
Transparency Life Sciences (TLS), a biopharmaceutical development company based in the US, has marked its official launch by unveiling a prototype of the crowdsourced web platform it will use to design clinical trial protocols more in tune with the needs of patients, physicians, medical experts and other stakeholders.
-
February 02, 2012
Parexel International is offering study sponsors a gateway to clinical trial services in Korea and across Asia through an alliance with the Seoul-based ASAN Medical Centre (AMC).
-
February 02, 2012
With a new chief executive officer (CEO) at the helm and a recent injection of funds from a Kuwait-based healthcare investment company, clinical research organisation (CRO) Clinart MENA is hoping to lead the way in making the Middle East and North Africa a premier destination for clinical trials.
-
January 31, 2012
Parexel International has tightened up its financial projections for fiscal 2012 after reporting operating income down by 19.9% year on year for the second quarter.
-
January 31, 2012
US-based contract research organisation PPD has expanded its existing strategic alliance with VirtualScopics, a company that provides imaging solutions to accelerate drug and medical device development, to include multiple therapeutic areas worldwide.
-
January 31, 2012
The Wellcome Trust Sanger Institute, the genomics research centre based in Cambridge, UK, is launching a survey to gauge the views of the public on how genetic research information should be used and shared.
-
January 26, 2012
Plans for a sharp increase in IT expenditure and further efforts to expand its commercial footprint during 2012 dampened Covance’s profit forecast for the year ahead, as fourth-quarter revenues came in below the analyst consensus but earnings per share (EPS) met expectations once restructuring and other charges were stripped out.
-
January 26, 2012
Spain’s Almirall has consolidated its existing relationship with BioFocus, the UK-based drug discovery specialist and Galapagos affiliate, by announcing a three-year research alliance aimed at delivering “drug development candidates directed to a key respiratory target of interest to Almirall”.
-
January 26, 2012
Charles River Laboratories has launched an online community as a forum for scientists to connect, interact and explore ‘Big Ideas’.
-
January 24, 2012
Parexel has expanded its alliance network for early-phase research by teaming up with University Hospitals Bristol National Health Service Foundation Trust (UH Bristol), one of the UK’s largest specialist teaching and research hospital trusts.